Plasma folate level and high-dose folate supplementation predict sulfadoxine-pyrimethamine treatment failure in pregnant women in Western kenya who have uncomplicated malaria.

UNLABELLED Sulfadoxine-pyrimethamine (SP) inhibits folate metabolism by the malaria parasite. We investigated the association between folate levels and SP failure in pregnant women. Data from a trial to assess the effect that folate supplementation has on SP failure in 467 pregnant women were analyzed. Plasma folate levels were determined at enrollment and at day 7. High baseline folate levels, high parasite densities, and age <20 years were risk factors for SP failure. High-dose (5 mg daily) folate supplementation or high folate levels at day 7 were independent risk factors. Therefore, pregnant women receiving SP should receive low-/moderate-dose folate supplementation. TRIAL REGISTRATION http://www.clinicaltrials.gov identifier: NCT00130065.

[1]  B. Nahlen,et al.  Pharmacokinetics of sulfadoxine-pyrimethamine in HIV-infected and uninfected pregnant women in Western Kenya. , 2007, The Journal of infectious diseases.

[2]  D. Vanderjagt,et al.  Nutritional Factors Associated with Anaemia in Pregnant Women in Northern Nigeria , 2007, Journal of health, population, and nutrition.

[3]  F. T. Ter Kuile,et al.  A Randomized Controlled Trial of Folate Supplementation When Treating Malaria in Pregnancy with Sulfadoxine-Pyrimethamine , 2006, PLoS clinical trials.

[4]  B. Greenwood,et al.  Lack of inhibition of the anti-malarial action of sulfadoxine-pyrimethamine by folic acid supplementation when used for intermittent preventive treatment in Gambian primigravidae. , 2006, The American journal of tropical medicine and hygiene.

[5]  Karen I Barnes,et al.  Blood folate concentrations and in vivo sulfadoxine-pyrimethamine failure in Malawian children with uncomplicated Plasmodium falciparum malaria. , 2005, The American journal of tropical medicine and hygiene.

[6]  A. Hubbard,et al.  The impact of age, temperature, and parasite density on treatment outcomes from antimalarial clinical trials in Kampala, Uganda. , 2004, The American journal of tropical medicine and hygiene.

[7]  M. Kolczak,et al.  Treatment history and treatment dose are important determinants of sulfadoxine-pyrimethamine efficacy in children with uncomplicated malaria in Western Kenya. , 2003, The Journal of infectious diseases.

[8]  M. Aidoo,et al.  Increased efficacy of sulfadoxine-pyrimethamine in the treatment of uncomplicated falciparum malaria among children with sickle cell trait in Western Kenya. , 2002, The Journal of infectious diseases.

[9]  K. Michaelsen,et al.  HIV and other predictors of serum folate, serum ferritin, and hemoglobin in pregnancy: a cross-sectional study in Zimbabwe. , 2001, The American journal of clinical nutrition.

[10]  G G Klee,et al.  Cobalamin and folate evaluation: measurement of methylmalonic acid and homocysteine vs vitamin B(12) and folate. , 2000, Clinical chemistry.

[11]  B. Brabin,et al.  Folacin, cobalamin, and hematological status during pregnancy in rural Kenya: the influence of parity, gestation, and Plasmodium falciparum malaria. , 1986, The American journal of clinical nutrition.

[12]  T. Stadtman,et al.  Vitamin B12 , 1971, Science.

[13]  D. Ntirushwa.  A strategic framework for malaria prevention and control during pregnancy in the African region , 2010 .